First and foremost, Habre recommends staying indoors as much as possible and keeping your windows closed. While the air may ...

First and foremost, Habre recommends staying indoors as much as possible and keeping your windows closed. While the air may ...

By not only trapping smoke and viruses, but destroying them too, these could be some of the most effective masks you can buy ...

Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in the U.S., the agency has cleared an under-the-skin version of the ...

Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed ...

The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...

Rich Scherr is a seasoned journalist and editor who has traveled across the U.S., Canada, and Europe, and spent more than a decade reviewing hotel room.

Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all gained FDA approval this year. These medications are "slated to make a big clinical ...

These devices reach levels that can't be tapped by creams and serums. Daley Quinn is a full-time journalist, editor, copywriter, and content creator covering beauty, wellness, health, and ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.